Works by Estrov, Z.

Results: 27

The Effect of Growth Hormone and IGF-I on Clonogenic Growth of Hematopoietic Cells in Leukemic Patients During Active Disease and During Remission - A Preliminary Report.

Published in:

Journal of Pediatric Endocrinology & Metabolism, 1993, v. 6, n. 1, p. 79, doi. 10.1515/jpem.1993.6.1.79

By:

Zadik, Z.;
Estrov, Z.;
Karov, Y.;
Hahn, T.;
Barak, Y.

Publication type:

Article

Twenty Years Follow-Up in a Patient with Multiple Myeloma.

Published in:

Acta Haematologica, 1981, v. 66, n. 4, p. 269, doi. 10.1159/000207134

By:

Berrebi, A.;
Estrov, Z.

Publication type:

Article

Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.

Published in:

2005

By:

Amit-Vazina, M.;
Shishodia, S.;
Harris, D.;
Van, Q.;
Wang, M.;
Weber, D.;
Alexanian, R.;
Talpaz, M.;
Aggarwal, B. B.;
Estrov, Z.

Publication type:

journal article

P1043: OUTCOME OF PATIENTS WITH PREFIBROTIC MYELOFIBROSIS FROM A LARGE ACADEMIC CENTER.

Published in:

HemaSphere, 2022, v. 6, p. 933, doi. 10.1097/01.HS9.0000847040.05235.94

By:

Masarova, L.;
Bose, P.;
Pemmaraju, N.;
Chifotides, H.;
Zhou, L.;
Estrov, Z.;
Kantarjian, H.;
Verstovsek, S.

Publication type:

Article

S149: LONG TERM OUTCOMES OF IFCG REGIMEN FOR FIRSTLINE TREATMENT OF PATIENTS WITH CLL WITH MUTATED IGHV AND WITHOUT DEL(17P)/TP53 MUTATION.

Published in:

HemaSphere, 2022, v. 6, p. 50, doi. 10.1097/01.HS9.0000843488.43813.af

By:

Jain, N.;
Thompson, P.;
Burger, J.;
Ferrajoli, A.;
Takahashi, K.;
Estrov, Z.;
Borthakur, G.;
Bose, P.;
Kadia, T.;
Pemmaraju, N.;
Sasaki, K.;
Konopleva, M.;
Jabbour, E.;
Garg, N.;
Wang, X.;
Kanagal‐Shamanna, R.;
Patel, K.;
Wang, W.;
Wang, S.;
Jorgensen, J.

Publication type:

Article

A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome.

Published in:

European Journal of Cancer Care, 2013, v. 22, n. 5, p. 605, doi. 10.1111/ecc.12065

By:

Daver, N.;
Vega‐Ruiz, A.;
Kantarjian, H.M.;
Estrov, Z.;
Ferrajoli, A.;
Kornblau, S.;
Verstovsek, S.;
Garcia‐Manero, G.;
Cortes, J.E.

Publication type:

Article

Adult stem cells and tissue repair.

Published in:

Bone Marrow Transplantation, 2003, v. 32, n. 1, p. S23, doi. 10.1038/sj.bmt.1703939

By:

Körbling, M;
Estrov, Z;
Champlin, R

Publication type:

Article

Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis.

Published in:

2006

By:

Körbling M;
Reuben JM;
Gao H;
Lee BN;
Harris DM;
Cogdell D;
Giralt SA;
Khouri IF;
Saliba RM;
Champlin RE;
Zhang W;
Estrov Z

Publication type:

Journal Article

SSBP2 is an in vivo tumor suppressor and regulator of LDB1 stability.

Published in:

Oncogene, 2010, v. 29, n. 21, p. 3044, doi. 10.1038/onc.2010.78

By:

Wang, Y.;
Klumpp, S.;
Amin, H. M.;
Liang, H.;
Li, J.;
Estrov, Z.;
Zweidler-McKay, P.;
Brandt, S. J.;
Agulnick, A.;
Nagarajan, L.

Publication type:

Article

Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in 87 myelofibrosis patients on a JAK1 and JAK2 inhibitor (INCB018424) clinical trial.

Published in:

2011

By:

Mesa RA;
Kantarjian H;
Tefferi A;
Dueck A;
Levy R;
Vaddi K;
Erickson-Viitanen S;
Thomas DA;
Cortes J;
Borthakur G;
Pardanani AD;
Estrov Z;
Verstovsek S;
Mesa, Ruben A;
Kantarjian, Hagop;
Tefferi, Ayalew;
Dueck, Amylou;
Levy, Richard;
Vaddi, Kris;
Erickson-Viitanen, Susan

Publication type:

journal article

Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.

Published in:

International Journal of Laboratory Hematology, 2009, v. 31, n. 1, p. 97, doi. 10.1111/j.1751-553X.2007.01010.x

By:

JILANI, I.;
WEI, C.;
BEKELE, B. N.;
ZHANG, Z. J.;
KEATING, M.;
WIERDA, W.;
FERRAJOLI, A.;
ESTROV, Z.;
KANTARJIAN, H.;
O'BRIEN, S. M.;
GILES, F. J.;
ALBITAR, M.

Publication type:

Article

The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia.

Published in:

2000

By:

Faderl, S;
Kantarjian, H M;
Estey, E;
Manshouri, T;
Chan, C Y;
Rahman Elsaied, A;
Kornblau, S M;
Cortes, J;
Thomas, D A;
Pierce, S;
Keating, M J;
Estrov, Z;
Albitar, M

Publication type:

journal article

Angioimmunoblastic lymphadenopathy in a patient with allergy to insulin: a case report.

Published in:

1981

By:

Naparstek, Y.;
Ben-Chetrit, E.;
Okon, E.;
Estrov, Z.;
Eliakim, M.

Publication type:

journal article

Secretory Piece and IgA Deficiency in a Patient with Waldenstrom's Macroglobulinemia.

Published in:

American Journal of Gastroenterology (Springer Nature), 1986, v. 81, n. 10, p. 995

By:

Nussinson, E.;
Lahav, M.;
Berebi, A.;
Estrov, Z.;
Zur, S.;
Resnitzky, P.

Publication type:

Article

Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia.

Published in:

Leukemia (08876924), 2014, v. 28, n. 7, p. 1543, doi. 10.1038/leu.2014.54

By:

Ravandi, F;
Arana Yi, C;
Cortes, J E;
Levis, M;
Faderl, S;
Garcia-Manero, G;
Jabbour, E;
Konopleva, M;
O'Brien, S;
Estrov, Z;
Borthakur, G;
Thomas, D;
Pierce, S;
Brandt, M;
Pratz, K;
Luthra, R;
Andreeff, M;
Kantarjian, H

Publication type:

Article

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 10, p. 2081, doi. 10.1038/leu.2013.165

By:

Takahashi, K;
Jabbour, E;
Wang, X;
Luthra, R;
Bueso-Ramos, C;
Patel, K;
Pierce, S;
Yang, H;
Wei, Y;
Daver, N;
Faderl, S;
Ravandi, F;
Estrov, Z;
Cortes, J;
Kantarjian, H;
Garcia-Manero, G

Publication type:

Article

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 4, p. 836, doi. 10.1038/leu.2012.319

By:

Chen, Y;
Kantarjian, H;
Pierce, S;
Faderl, S;
O'Brien, S;
Qiao, W;
Abruzzo, L;
de Lima, M;
Kebriaei, P;
Jabbour, E;
Daver, N;
Kadia, T;
Estrov, Z;
Garcia-Manero, G;
Cortes, J;
Ravandi, F

Publication type:

Article

A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission.

Published in:

Leukemia (08876924), 2012, v. 26, n. 11, p. 2428, doi. 10.1038/leu.2012.153

By:

Boumber, Y;
Kantarjian, H;
Jorgensen, J;
Wen, S;
Faderl, S;
Castoro, R;
Autry, J;
Garcia-Manero, G;
Borthakur, G;
Jabbour, E;
Estrov, Z;
Cortes, J;
Issa, J-P;
Ravandi, F

Publication type:

Article

Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.

Published in:

2009

By:

Carter, B. Z.;
Mak, D. H.;
Woessner, R.;
Gross, S.;
Schober, W. D.;
Estrov, Z.;
Kantarjian, H.;
Andreeff, M.

Publication type:

journal article

Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias.

Published in:

2004

By:

Zhao, S.;
Konopleva, M.;
Cabreira-Hansen, M.;
Xie, Z.;
Hu, W.;
Milella, M.;
Estrov, Z.;
Mills, G.B.;
Andreeff, M.

Publication type:

journal article

Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-?B activation mediated by EBV-derived latent membrane protein 1.

Published in:

Leukemia (08876924), 2003, v. 17, n. 11, p. 2196, doi. 10.1038/sj.leu.2403130

By:

Thompson, M. P.;
Aggarwal, B. B.;
Shishodia, S.;
Estrov, Z.;
Kurzrock, R.

Publication type:

Article

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.

Published in:

2001

By:

Verstovsek, S;
Kantarjian, H;
Estey, E;
Aguayo, A;
Giles, F J;
Manshouri, T;
Koller, C;
Estrov, Z;
Freireich, E;
Keating, M;
Albitar, M

Publication type:

journal article

Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing.

Published in:

2001

By:

Sarriera, J E;
Albitar, M;
Estrov, Z;
Gidel, C;
Aboul-Nasr, R;
Manshouri, T;
Kornblau, S;
Chang, K-S;
Kantarjian, H;
Estey, E

Publication type:

journal article

Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.

Published in:

1999

By:

Andreeff, M;
Jiang, S;
Zhang, X;
Konopleva, M;
Estrov, Z;
Snell, V E;
Xie, Z;
Okcu, M F;
Sanchez-Williams, G;
Dong, J;
Estey, E H;
Champlin, R C;
Kornblau, S M;
Reed, J C;
Zhao, S

Publication type:

journal article

DNA in situ hybridization of individual colonies to determine lineage derivation in leukemia.

Published in:

1998

By:

Kurzrock, R;
Talpaz, M;
Beran, M;
Harris, D;
Estrov, Z

Publication type:

research

Chronic myelogenous leukemia: biology and therapy.

Published in:

1999

By:

Faderl, Stefan;
Talpaz, Moshe;
Faderl, S;
Talpaz, M;
Estrov, Z;
Kantarjian, H M

Publication type:

journal article

Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph<sup>1</sup>)-positive acute lymphoblastic leukemia: Studies on two newly established Ph<sup>1</sup>-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).

Published in:

Journal of Cellular Physiology, 1996, v. 166, n. 3, p. 618, doi. 10.1002/(SICI)1097-4652(199603)166:3<618::AID-JCP17>3.0.CO;2-2

By:

Estrov, Z.;
Talpaz, M.;
Zipf, T. F.;
Kantarjian, H. M.;
Ku, S.;
Ouspenskaia, M. V.;
Hirsch-Ginsberg, C.;
Huh, Y.;
Yee, G.;
Kurzrock, R.

Publication type:

Article